What started off personal, developed into a passion to improve neurological health and slow cognitive decline through sleep science.
Karen Crow, one of the co-founders of NeuroGeneces, encountered personal challenges as her mother battled Alzheimer's and her son struggled with a sleep disorder. During her research into these conditions, she discovered that sleep serves as a gateway to the brain, providing valuable insights into neurophysiology and creating opportunities to measure and enhance brain function.
Prioritizing brain health begins with assessing brain function and monitoring changes annually to provide early interventions when they are most effective in changing the trajectory of neurodegeneration.
Now Karen’s personal mission is to develop technology to monitor brain function and enhance long-lasting neurological health.
She connected with cofounder Jason Worchel, M.D., a neuropsychiatrist and recognized expert in neurostimulation. Together they launched NeuroGeneces to develop safe, natural, and proven ways to measure and improve brain health.
The NeuroGeneces Team
STRATEGIC ADVISORS
Paul Butler, former CTO of Honeywell Processing Solutions, and former COO of Lumidigm, a biosensor company, brings 35 years of deep experience in executive leadership, business and organizational strategy, customer-centered product design and marketing (including numerous biosensor products), management, and revenue generation. He has a track record of transitioning ambitious concepts into valuable products or services. Paul’s role in NeuroGevity commercialization includes business model design, product and service strategy, and manufacturing and logistics processes/relationships.
Robert Bender, PhD, has over 40 years of experience in life sciences and healthcare. He’s been a serial entrepreneur, a venture capitalist, and is currently Chairman of the Board of Revivo Therapeutics, a pharmaceutical company developing a new class of therapies to treat neurodegenerative diseases. Robert has brought multiple pharmaceutical products to market, and brings knowledge of the neuroscience venture capital space.
Murdoc Khaleghi, MD, is a physician, researcher, author, and serial health tech entrepreneur, with numerous research fellowships, including the American Heart Association, NIH, the Howard Hughes Medical Institute, and Stein Institute for Research on Aging. Murdoc advises select startups, and has a proven track record of successful exits, including 5 IPOs and unicorns.
Avi Yaron is an entrepreneur, executive chairman and strategic adviser. He brings extensive knowledge of neurotech devices in the medical/wellness arenas, with a focus on personalized predictive preventative solutions to improve well-being. He cofounded Joy Ventures to pioneer and cultivate a neuro-wellness consumer product ecosystem, and cofounded HealthYA Ventures Lab to focus on disruptive health tech startups that target significant unmet needs. The NeuroGeneces team knows that securing investor funding will be critical for commercialization: Robert, Murdoc and Avi provide fundraising experience, strategic advice and access to contacts in this area.